Cumberland Pharmaceuticals Inc
CPIX
CPIX: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, RediTrex, Sancuso, Vaprisol and Vibativ.
moreShow CPIX Financials
Recent trades of CPIX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CPIX's directors and management
Government lobbying spending instances
-
$20,000 Jan 21, 2021 Issue: Health Issues
New patents grants
-
Patent Title: Thromboxane receptor antagonists in aerd/asthma Feb. 07, 2023
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Feb. 23, 2021
-
Patent Title: Doses and methods for administering telavancin Aug. 25, 2020
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Mar. 10, 2020
-
Patent Title: Compositions and methods of treating muscular dystrophy with thromboxane-a Oct. 29, 2019
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jun. 11, 2019
-
Patent Title: Compositions and methods of treating muscular dystrophy with thromboxane-a Sep. 04, 2018
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jul. 10, 2018
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Apr. 03, 2018
-
Patent Title: Stabilized statin formulations Nov. 21, 2017
-
Patent Title: Compositions and methods of treating cardiac fibrosis with ifetroban Jul. 04, 2017
-
Patent Title: Treating critically ill patients with intravenous ibuprofen May. 16, 2017
-
Patent Title: Lactulose for bowel evacuation Jun. 28, 2016
-
Patent Title: Acetylcysteine compositions and methods of use thereof May. 03, 2016
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Mar. 29, 2016
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Sep. 22, 2015
-
Patent Title: Treating patients with intravenous ibuprofen Aug. 25, 2015
-
Patent Title: Injectable ibuprofen formulation Jul. 07, 2015
-
Patent Title: Injectable ibuprofen formulation Jul. 07, 2015
-
Patent Title: Administration of intravenous ibuprofen Apr. 21, 2015
-
Patent Title: Acetylcysteine composition and uses thereof Feb. 10, 2015
-
Patent Title: Stabilized statin formulations Jan. 13, 2015
-
Patent Title: Treating critically ill patients with intravenous ibuprofen Oct. 28, 2014
-
Patent Title: Lactulose for bowel evacuation Jul. 15, 2014
-
Patent Title: Treating patients with intravenous ibuprofen May. 27, 2014
-
Patent Title: Acetycysteine compositions and methods of use thereof May. 13, 2014
-
Patent Title: Acetylcysteine composition and uses thereof Feb. 18, 2014
-
Patent Title: Acetylcysteine composition and uses thereof Mar. 19, 2013
-
Patent Title: Stabilized statin formulations Feb. 12, 2013
-
Patent Title: Acetylcysteine composition and uses therefor Apr. 03, 2012
Federal grants, loans, and purchases
Followers on CPIX's company Twitter account
Number of mentions of CPIX in WallStreetBets Daily Discussion
Recent insights relating to CPIX
Recent picks made for CPIX stock on CNBC
ETFs with the largest estimated holdings in CPIX
Flights by private jets registered to CPIX